UBS Group
BDSX icon

UBS Group’s Biodesix BDSX Stock Holding History

UBS Group’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$534K Buy
+36,808
New +$456K ﹤0.01% 6035
2025
Q3 		– Sell
-1
Closed -$6 – 10341
2025
Q2 		$6 Sell
1
-74
-99% -$597 ﹤0.01% 10167
2025
Q1 		$931 Sell
75
-38
-34% -$729 ﹤0.01% 9613
2024
Q4 		$3.47K Buy
113
+100
+769% +$2.94K ﹤0.01% 8875
2024
Q3 		$445 Sell
13
-91
-88% -$3.13K ﹤0.01% 8941
2024
Q2 		$3.19K Buy
+104
New +$2.97K ﹤0.01% 8247
2023
Q4 		– Sell
-135
Closed -$4.44K – 9310
2023
Q3 		$4.44K Buy
135
+127
+1,588% +$3.53K ﹤0.01% 7443
2023
Q2 		$185 Hold
8
– – ﹤0.01% 8412
2023
Q1 		$279 Sell
8
-210
-96% -$8.62K ﹤0.01% 9100
2022
Q4 		$10K Buy
218
+210
+2,625% +$5.71K ﹤0.01% 8580
2022
Q3 		$0 Sell
8
-203
-96% -$7.83K ﹤0.01% 10330
2022
Q2 		$7K Buy
211
+187
+779% +$6.08K ﹤0.01% 8454
2022
Q1 		$1K Sell
24
-170
-88% -$11.1K ﹤0.01% 9840
2021
Q4 		$21K Buy
194
+186
+2,325% +$24.3K ﹤0.01% 7771
2021
Q3 		$1K Sell
8
-141
-95% -$26.7K ﹤0.01% 9138
2021
Q2 		$39K Buy
149
+134
+893% +$42.1K ﹤0.01% 6651
2021
Q1 		$6K Sell
15
-82
-85% -$36.6K ﹤0.01% 8220
2020
Q4 		$39K Buy
+97
New +$30.2K ﹤0.01% 6398

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

UBS Group's BDSX Position: Q1 2026 in Review

UBS Group opened a new position in Biodesix (BDSX) in Q1 2026: 36,808 shares worth $534K. The stake represents ﹤0.01% of the portfolio and ranks #6035 among its holdings. This is a return to the name: UBS Group previously reported a position in BDSX as recently as Q2 2025.

UBS Group first reported a position in BDSX in Q4 2020 and has held it in 18 quarters since. 40 funds tracked by Wall St. Rank hold BDSX as of Q1 2026.

  • UBS Group held 36,808 shares of Biodesix worth $534K as of Q1 2026.
  • Biodesix was a new UBS Group position in Q1 2026.
  • Biodesix made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #6035 holding.
  • UBS Group first reported a position in Biodesix in Q4 2020 and has held it in 18 quarters since.
  • 40 funds tracked by Wall St. Rank held Biodesix as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.